Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 203049
Company: HIKMA PHARM CO LTD
Company: HIKMA PHARM CO LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | AP | Yes | Yes |
ARGATROBAN | ARGATROBAN | 50MG/50ML (1MG/ML) | INJECTABLE;INJECTION | Prescription | AP | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/05/2012 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203049s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/203049s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203049_argatroban_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203049Orig1s000SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/22/2020 | SUPPL-7 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203049s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/203049Orig1s007ltr.pdf | |
05/26/2016 | SUPPL-5 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203049s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203049Orig1s005ltr.pdf | |
09/30/2016 | SUPPL-4 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203049s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203049Orig1s004ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/203049Orig1s004.pdf | |
10/16/2014 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/13/2013 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/22/2020 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/203049s007lbl.pdf | |
09/30/2016 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203049s004lbl.pdf | |
05/26/2016 | SUPPL-5 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203049s005lbl.pdf | |
01/05/2012 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203049s000lbl.pdf |
ARGATROBAN
INJECTABLE;INJECTION; 250MG/2.5ML (100MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 206698 | AMNEAL PHARMS CO |
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 091665 | ENDO OPERATIONS |
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 201811 | FRESENIUS KABI USA |
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | Yes | AP | 203049 | HIKMA PHARM CO LTD |
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 204120 | HOSPIRA |
ARGATROBAN | ARGATROBAN | 250MG/2.5ML (100MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 202626 | MYLAN INSTITUTIONAL |
INJECTABLE;INJECTION; 50MG/50ML (1MG/ML)
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ARGATROBAN | ARGATROBAN | 50MG/50ML (1MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 214235 | CAPLIN |
ARGATROBAN | ARGATROBAN | 50MG/50ML (1MG/ML) | INJECTABLE;INJECTION | Prescription | No | AP | 217848 | GLAND PHARMA LTD |
ARGATROBAN | ARGATROBAN | 50MG/50ML (1MG/ML) | INJECTABLE;INJECTION | Prescription | Yes | AP | 203049 | HIKMA PHARM CO LTD |